Colonoscopy Detects Neoplasias Not Found by Sigmoidoscopy

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 10
Volume 9
Issue 10

PORTLAND, Oregon-Two large studies of colonoscopy as a primary screening tool for colon cancer show that the procedure detects advanced proximal neoplasias that would not be found with sigmoidoscopy.

PORTLAND, Oregon—Two large studies of colonoscopy as a primary screening tool for colon cancer show that the procedure detects advanced proximal neoplasias that would not be found with sigmoidoscopy.

David A. Lieberman, MD, of Oregon Health Sciences University and Portland Veterans Affairs Medical Center, led a study of 3,121 asymptomatic patients at 13 Veterans Affairs centers who underwent colonoscopy. The examination found one or more neoplastic lesions in 37.5% of patients. Of the 1,765 patients with no polyps in the distal colon, 48 (2.7%) were found to have advanced proximal neoplasms.

Patients with adenomas of any size in the distal colon were more likely to have advanced proximal neoplasia than were patients with no distal adenomas (odds ratio for patients with small adenomas, 2.6; for patients with large adenomas, 3.4). However, 66 (52%) of the 128 patients with advanced proximal neoplasia had no distal adenomas. Sigmoidoscopy would have missed these abnormalities (N Engl J Med 343:162-168, 2000).

Few Serious Complications

Of the more than 3,000 colonoscopies performed, all by the study investigators, who were selected because of their extensive experience with colonoscopy, there were only 10 serious complications during or immediately after the procedure (0.3%). There were six cases of gastrointestinal bleeding requiring hospitalization and one case each of myocardial infarction, cerebrovascular accident, Fornier’s gangrene, and thrombophlebitis. There were no perforations and no deaths related to the procedure.

Dr. Lieberman reported that 73.3% of the cancers identified on screening had no nodal involvement or distal spread. “These data suggest that screening with colonoscopy in asymptomatic men can detect early and potentially curable advanced neoplasia,” he said.

In the second study, from Indiana University, 1,994 asymptomatic adults underwent colon-oscopy screening. Thomas F. Imperiale, MD, reported that those who had polyps in the distal colon were more likely to have advanced proximal neoplasia than those without distal polyps. However, 23 (46%) of 50 patients with advanced proximal neoplasia had no distal polyps, for a prevalence of 1.5% (23 of 1,564 persons with no distal polyps).

Time to ‘Go the Distance’

In an editorial, Daniel K. Podolsky, MD, of Massachusetts General Hospital, called for both government and private insurers to provide coverage for primary colon cancer screening with colonoscopy for all average-risk persons 50 years of age or older.

“Relying on flexible sigmoidoscopy is as clinically logical as performing mammography of one breast to screen women for breast cancer,” Dr. Podolsky said. “It is time to go the distance.”

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content